Manus Bio is awarded a Phase I SBIR Grant from the National Science Foundation for the development of an advanced fermentation process for renewable chemicals

CAMBRIDGE, Mass., December 15, 2013 - Manus Bio, a leader in metabolic engineering and synthetic biology, announced today that it has been awarded a prestigious National Science Foundation grant under the Small Business Innovation Research (SBIR) program. This Phase I award ($150,000) supports the development of an advanced fermentation process for the synthesis of a high value biochemical used in a variety of consumer products. The full project abstract can be found at

About Manus Bio

Manus Bio is a global leader in the use of advanced fermentation technology for manufacturing complex, bioactive natural products as flavors, fragrances, food ingredients, biopesticides, and pharmaceuticals. The core team and technology are from MIT, and the company is headquartered in Cambridge, MA, USA. For more information, visit